Advances in CLOT Treatment (ACT)

SECTION 1: CLINICAL

SECTION 2: DIAGNOSIS

SECTION 3: TENECTEPLASE (TNK) AND CLOT TREATMENT

SECTION 4: NOACs IN CLOT TREATMENT

SECTION 5: THROMBOSIS AND CORONARY ARTERY DISEASE

SECTION 6: THROMBOSIS AND HYPERTENSION

SECTION 7: THROMBOSIS AND HEART FAILURE

SECTION 8: THROMBOSIS AND DYSLIPIDEMIA

SECTON 9: THROMBOSIS AND DIABETES MELLITUS

SECTION 10: THROMBOSIS AND ARRHYTHMIA

SECTION 11: THROMBOSIS AND CARDIOMYOPATHY

SECTION 12: THROMBOSIS AND RHD

SECTION 13: DVT

SECTION 14: THROMBOSIS AND PAD

SECTION 15: THROMBOSIS AND CAROTID ARTERY DISEASE

SECTION 16: THROMBOSIS AND VERTEBRAL ARTERY DISEASE

SECTION 17: THROMBOSIS AND STROKE INTRACEREBRAL ARTERIAL DISEASE

SECTION 18: THROMBOSIS AND KIDNEY

SECTION 19: THROMBOSIS AND CARDIAC SURGERY

SECTION 20: THROMBOSIS AND CRITICAL CARE

SECTION 21: THROMBOSIS IN EMERGENCY AND URGENT CARE

SECTION 22: THROMBOSIS AND SEPSIS

SECTION 23: THROMBOSIS AND WOMEN

SECTION 24: THROMBOSIS AND EYE

SECTION 25: THROMBOSIS AND LUNG

SECTION 26: NOAC AND DRUGS INTERACTION

SECTION 27: COVID-INFLICTED COAGULOPATHY

SECTION 28: CLOT IN ECMO

SECTION 29: THROMBOSIS AND COVID VACCINATION

SECTION 30: THROMBOSIS AND NUTRITION

SECTION 31: CARDIO-ONCOLOGY AND THROMBOSIS

SECTION 32: POSTMITRAL CLIP THROMBOSIS

SECTION 33: PEDIATRICS AND THROMBOSIS

SECTION 34: SKIN AND THROMBOSIS

SECTION 35: THROMBOSIS AND AVN

SECTION 36: FUTURE DIRECTIONS IN THROMBOSIS CARE